Shaping the Next Era of Biologics Manufacturing in North Carolina

Home | Knowledge Center | Resource Library | Shaping the Next Era of Biologics Manufacturing in North Carolina
FUJIFILM Biotechnologies has built a next-generation biologics manufacturing hub in North Carolina, led by Senior Vice President Laurie Braxton. The new Holly Springs site is one of North America’s largest end-to-end cell culture facilities and launched cGMP production in 2025 with eight 20,000 L bioreactors. There is a phased expansion plan that adds significant capacity by 2028, all underpinned by rigorous quality, digital transparency, and a paperless, automated operation. The company’s kojoX™ network philosophy ensures equivalency across sites, accelerating improvement while de-risking scale-up and tech transfer. Rooted in North Carolina’s mature life sciences ecosystem, the strategy aligns with onshoring trends, workforce development, and long-term resilience. Learn more in this insight brief.
Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy